AMBS is trying to position itself so that at the J
Post# of 30028
Posted On: 12/08/2014 9:57:20 AM
AMBS is trying to position itself so that at the JP Morgan Conference in January, it will be the Belle of the Ball:
LymPro Launch,
MANF/RP Orphan,
MANF/Wolfram's/Eye Data,
Eltoprazine 2b Clinical Trial,
ESS Orphan
Phenoguard's "Plethora" of other discoveries.
I THINK INSTITUTIONS WILL SEE A BUYING OPPORTUNITY once AMBS up lists in late January or early February. Dr. Rubenfeld may replace Gerald as our go to guy SPOKESMAN because of his credibility.
LymPro Launch,
MANF/RP Orphan,
MANF/Wolfram's/Eye Data,
Eltoprazine 2b Clinical Trial,
ESS Orphan
Phenoguard's "Plethora" of other discoveries.
I THINK INSTITUTIONS WILL SEE A BUYING OPPORTUNITY once AMBS up lists in late January or early February. Dr. Rubenfeld may replace Gerald as our go to guy SPOKESMAN because of his credibility.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼